Clinical trial Recruiting at 1 site Interventional Ages 18 to 59 Women only

Psyllium versus fructooligosaccharide for improving bowel transit in women with functional constipation

Official title: Effects of Chronic Ingestion of Fructooligosaccharide and Psyllium on Intestinal Transit Time in Women Diagnosed With Functional Constipation: A Randomized, Crossover, Double-Blind Clinical Trial

Run by Federal University of Minas Gerais · NCT07202481 · Data updated 2026-11-12

This will test whether taking 20 g daily of psyllium or fructooligosaccharide for six days helps improve bowel movements and intestinal transit in adult women with functional constipation.

Quick facts

Study typeInterventional
Ages18 Years to 59 Years
SexWomen only
Enrollment25 (estimated)
SponsorFederal University of Minas Gerais
Academic / other
Locations1 site (Belo Horizonte, Minas Gerais)
StatusRecruiting
StartedMarch 14, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedMarch 24, 2026
Trial IDNCT07202481 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women aged 18–59 with functional constipation who currently consume less than about 25–30 g of fiber per day, are non-smokers, and have no other gastrointestinal disease are ideal candidates.

Probably not a fit

Patients with diabetes, significant thyroid disease, opioid use, prior surgery affecting gastrointestinal transit, delayed gastric emptying at baseline, or those already meeting adequate fiber intake may not receive benefit from these interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized crossover trial enrolls women aged 18–59 with functional constipation who consume less than recommended dietary fiber. Each participant will undergo 6-day periods of 20 g/day fiber (divided into two 10 g doses) with psyllium, fructooligosaccharide, and a control in random order, and will keep daily bowel and diet records. At the end of each period participants will have scintigraphic nuclear medicine imaging to measure intestinal transit, and laxatives are stopped before imaging. The crossover design allows within-person comparisons of effectiveness and side effects between the two fibers and control.

Why it matters

Potential benefit: If successful, the trial could identify which common fiber supplement more quickly improves bowel regularity and intestinal transit for women with functional constipation.

How similar studies have gone: Psyllium is well-supported by prior studies for relieving constipation and fructooligosaccharide has mixed evidence, so elements of this approach are established though direct short-term crossover comparisons with scintigraphy are less common.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Female participants aged 18-59 years.
* Willingness to sign the Informed Consent Form .
* No restrictions on the consumption of egg or gluten.
* No history or diagnosis of gastrointestinal diseases other than functional constipation.
* Non-smokers.
* No use of prebiotics, probiotics, synbiotics, or antibiotics at least 10 days prior to the study.
* No previous surgery affecting gastrointestinal transit.
* Willingness to discontinue the use of laxatives at least 4 days prior to scintigraphic imaging.
* Participants who do not consume adequate dietary fiber (25-30 g/day) as assessed by dietary recall.
* No confirmed or suspected pregnancy during the study.
* No self-reported menopause

Exclusion Criteria

* Diagnosis of diabetes, severe hyperthyroidism, or hypothyroidism.
* Use of opioid medications.
* Delayed gastric emptying at 4 hours during the placebo period (participants meeting this criterion will be excluded from final analysis).

Where it's running

  • School of Nursing, Federal University of Minas Gerais
    Belo Horizonte, Minas Gerais, Brazil
    Recruiting

Study contacts

  • Principal investigator: Simone de Vasconcelos Generoso, PhD — Department of Nutrition, Federal University of Minas Gerais
  • Study coordinator: Simone de Vasconcelos Generoso, PhD
  • Email: simonenutufmg@gmail.com
  • Phone: 55(031) 988128650

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.